MELISSA LINARES: Open Payments
NPI 1699047241 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 85 payments from 17 companies in 2025. Trend: 2023 $1,626 · 2024 $1,453 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $294 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $224 |
| PFIZER INC. | 9 | $153 |
| Abbott Laboratories | 8 | $147 |
| Avvisto Therapeutics, LLC | 7 | $114 |
| SANOFI-AVENTIS U.S. LLC | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Lilly USA, LLC | 3 | $60 |
| Exact Sciences Corporation | 3 | $53 |
Products named: JARDIANCE, Ozempic, FREESTYLE LIBRE 3, PREVNAR 20, CYCLOSET, TZIELD, Wegovy, BREZTRI.
Industry payments across TX — which companies pay providers there.
